Shire makes decentralized EU filing for Elvanse for adults
This article was originally published in Scrip
Executive Summary
In a distraction from its recent disappointment with Vyvanse (lisdexamfetamine dimesylate) in major depressive disorder, Shire has made a filing for the product in the UK as Elvanse for adults newly diagnosed with attention-deficit hyperactivity disorder (ADHD).